Innovate To Create
Zymeron is a research-based biotechnology company that discover, develop and commercialize innovative technologies to deliver products and solutions with step-change performance.
Rx – Precision
Therapeutics
Target protein degradation; pathogen agnostic antibacterials, antivirals and antifungals; long lasting drug implants; bone marrow delivery systems; adjuvanted recombinant nanoparticle vaccine platform. Infectious diseases.
Dx – Rapid Diagnostics
& Detection
Our interdisciplinary team of chemists, engineers and microbiologists innovate and develop rapid diagnostic tests and sensing technologies designed for end users in field, clinical offices, hospital bedsides, and at home.
MCM – Medical
Countermeasures
Game-changing MCM technologies to detect, prevent and mitigate adverse health effects imposed by emerging chem and bio threats. Work with industrial partners and federal labs to advance government initiatives.
All
Technologies
Zymeron develops technologies primarily for the management of infectious agents and infectious diseases, and transforms laboratory discoveries and innovations to practical and higher performing solutions for entry into the market.
Our Capabilites
Our capabilities statement is organized as success stories in each of our technology focus areas, including rapid reduction of concept to practice, feasibility demonstration, prototyping and pilot production, human factors and usability engineering, design controls to ensure safe and effective products, and our commitment to excellence.
Our Partners
We have an extended list of partners in academia, industry, government, and non-profit organizations. We work closely with numerous government agencies including the Department of Defense and the Department of Health and Human Services to develop innovative products to meet the nation’s health and defense needs. We commercialize advanced materials and health-related technologies and bring them to market in partnership with commercial entities.